[Calculation of cardiovascular risk in elderly patients]

Meral Kayıkçıoğlu1

  • 1Department of Cardiology, Ege University Faculty of Medicine, İzmir, Turkey. meral.kayikcioglu@ege.edu.tr.

Insights

Modifying cardiovascular risk factors in older adults can prevent events. The SCORE-old age scale accurately predicts cardiovascular mortality in those aged 65-80, reducing overestimated risks and unnecessary medication.

Area of Science:

  • Cardiology
  • Geriatrics
  • Preventive Medicine

Background:

  • Cardiovascular (CV) risk factors remain relevant in advanced age, with potential for CV event reduction through risk factor modification.
  • Standard CV risk calculation scales are often unsuitable for older adults (>65 years), frequently leading to risk overestimation.
  • Accurate CV risk assessment in the elderly is crucial to avoid overtreatment and manage health effectively.

Purpose of the Study:

  • To describe the procedure for predicting cardiovascular risk in older adults.
  • To introduce and validate the SCORE-old age scale for improved CV risk assessment in the 65-80 age group.
  • To highlight the benefits of using the SCORE-old age scale in clinical practice for the elderly.

Main Methods:

  • Review of existing literature on cardiovascular risk assessment in aging populations.
  • Validation of the SCORE-old age scale, derived from the SCORE risk calculation scale, for individuals aged 65-80 years.
  • Comparison of the predictive accuracy of the SCORE-old age scale against standard CV risk scales for CV mortality.

Main Results:

  • The SCORE-old age scale demonstrates superior prediction of CV mortality in the 65-80 age group compared to standard risk scales.
  • Implementation of the SCORE-old age scale can lead to a decrease in the erroneous overestimation of CV risk in the elderly.
  • Accurate risk stratification using the SCORE-old age scale has the potential to reduce unnecessary drug prescriptions in older patients.

Conclusions:

  • The SCORE-old age scale is a validated tool for predicting cardiovascular mortality in adults aged 65-80 years.
  • Utilizing the SCORE-old age scale improves the accuracy of CV risk assessment in the elderly.
  • Adoption of the SCORE-old age scale can optimize cardiovascular risk management and reduce polypharmacy in aging populations.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
941
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
274
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
308
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
564
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
267
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
287